India rejects EFTA s demand for data exclusivity provision, protecting the generic drug industry. Secretary Barthwal emphasizes India s support for the industry. Exclusivity is beyond TRIPS agreement. EFTA has 29 FTAs with 40 partner countries, including Canada, Chile, China, Mexico, and Korea.
The surge of patent expiration of branded drugs is the most significant factor driving the growth for this market. Growing prevalence of chronic diseases,.
Data Bridge Market Research completed a qualitative study titled Generic Drug Market with 100+ market data tables, pie charts, graphs, and figures spread
Dublin, May 31, 2021 (GLOBE NEWSWIRE) The "Global Generic Drugs Market 2020-2025" report has been added to ResearchAndMarkets.com's offering. The global market for generic drugs should grow from $411.6 billion in 2020 to $650.3 billion by 2025, at a compound annual growth rate (CAGR) of 9.6% for the period of 2020-2025. The nature and structure of the generic drug industry is discussed, with profiles of the leading 20+ generic drug companies and an update on M&A activity. Five-year sales forecasts are provided for the national markets and the major therapeutic categories of the products involved. This report is being published at a time when the pharmaceutical industry faces challenges and changes more radical than any it has faced in the last half-century. The worldwide economic recession in 2008 has had a profound impact on an industry that is normally resilient to the usual ups and downs of commercial life. Apart from the sometimes painful process of cutting co
are for generics. rosemary gibbson says it s all part of china s plan. in five to 10 years we re at risk of losing our generic drug industry because china will use the same playbook and undercut our own producers and drive them out of business. that s already happening. as the trade war continues china is now threatening to weaponize rare earth minerals. the national security concern now is what happens if china wants to say cut the supply for our medicines or alter its quality? many of the medicines used on our own troops and veterans can also be sourced back to china. i have no doubt that they would consider weaponizing their dominance of the pharmaceutical market if they felt that would give them an advantage over us strategically. the u.s. commission on china is holding a hearing on this threat on july 31st. sandra. experts say the first step is identifying what drugs are made in china.